questionsmedicales.fr
Maladies de l'appareil respiratoire
Infections de l'appareil respiratoire
Pneumopathie infectieuse
Pneumopathie bactérienne
Pneumonie à Chlamydia
Pneumonie à Chlamydia : Questions médicales fréquentes
Diagnostic
5
Pneumonie
Chlamydia pneumoniae
Radiographie
Analyse de sang
Pneumonie
Infection respiratoire
Symptômes
5
Maux de tête
Douleurs musculaires
Prévention
5
Vaccins
Chlamydia pneumoniae
Hygiène des mains
Prévention
Traitements
5
Antibiotiques
Doxycycline
Antiviraux
Infection bactérienne
Durée du traitement
Infection
Soins de soutien
Hydratation
Résistance aux antibiotiques
Efficacité
Complications
5
Complications
Insuffisance respiratoire
Complications
Personnes âgées
Suivi médical
Complications
Récupération
Soins intensifs
Facteurs de risque
5
Facteurs de risque
Immunodépression
Personnes âgées
Pneumonie
Maladies chroniques
Diabète
Stress
Système immunitaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Pneumonie à Chlamydia : Questions médicales les plus fréquentes",
"headline": "Pneumonie à Chlamydia : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Pneumonie à Chlamydia : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-27",
"dateModified": "2025-04-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Pneumonie à Chlamydia"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pneumopathie bactérienne",
"url": "https://questionsmedicales.fr/mesh/D018410",
"about": {
"@type": "MedicalCondition",
"name": "Pneumopathie bactérienne",
"code": {
"@type": "MedicalCode",
"code": "D018410",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.730.610.540"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Pneumonie à Chlamydia",
"alternateName": "Chlamydial Pneumonia",
"code": {
"@type": "MedicalCode",
"code": "D061387",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Guangming Zhong",
"url": "https://questionsmedicales.fr/author/Guangming%20Zhong",
"affiliation": {
"@type": "Organization",
"name": "Departments of Microbiology, Immunology, and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA Xuemin5908@sina.com Zhongg@uthscsa.edu."
}
},
{
"@type": "Person",
"name": "Kenneth W Beagley",
"url": "https://questionsmedicales.fr/author/Kenneth%20W%20Beagley",
"affiliation": {
"@type": "Organization",
"name": "School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Qld, Australia."
}
},
{
"@type": "Person",
"name": "Martina Jelocnik",
"url": "https://questionsmedicales.fr/author/Martina%20Jelocnik",
"affiliation": {
"@type": "Organization",
"name": "Animal Research Centre, University of the Sunshine Coast, Sippy Downs, QLD, Australia."
}
},
{
"@type": "Person",
"name": "Nicole Borel",
"url": "https://questionsmedicales.fr/author/Nicole%20Borel",
"affiliation": {
"@type": "Organization",
"name": "Institute of Veterinary Pathology, Department of Pathobiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland."
}
},
{
"@type": "Person",
"name": "Wilhelmina M Huston",
"url": "https://questionsmedicales.fr/author/Wilhelmina%20M%20Huston",
"affiliation": {
"@type": "Organization",
"name": "School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Clinical, radiological and pathological characteristics of moderate to fulminant psittacosis pneumonia.",
"datePublished": "2022-07-11",
"url": "https://questionsmedicales.fr/article/35816485",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0270896"
}
},
{
"@type": "ScholarlyArticle",
"name": "Atypical pneumonia caused by Chlamydia abortus in HIV patient: a case report.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39334069",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12890-024-03295-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "4-Chloroisocoumarins as Chlamydial Protease Inhibitors and Anti-Chlamydial Agents.",
"datePublished": "2024-03-28",
"url": "https://questionsmedicales.fr/article/38611800",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules29071519"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Viral and chlamydial conjunctivitis].",
"datePublished": "2024-10-24",
"url": "https://questionsmedicales.fr/article/39454485",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jfo.2024.104337"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical identification and microbiota analysis of",
"datePublished": "2023-06-26",
"url": "https://questionsmedicales.fr/article/37434780",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fcimb.2023.1157540"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012140"
},
{
"@type": "ListItem",
"position": 3,
"name": "Infections de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012141"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pneumopathie infectieuse",
"item": "https://questionsmedicales.fr/mesh/D011014"
},
{
"@type": "ListItem",
"position": 5,
"name": "Pneumopathie bactérienne",
"item": "https://questionsmedicales.fr/mesh/D018410"
},
{
"@type": "ListItem",
"position": 6,
"name": "Pneumonie à Chlamydia",
"item": "https://questionsmedicales.fr/mesh/D061387"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Pneumonie à Chlamydia - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Pneumonie à Chlamydia",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Pneumonie à Chlamydia",
"description": "Comment diagnostiquer la pneumonie à Chlamydia ?\nQuels examens sont recommandés ?\nLes symptômes aident-ils au diagnostic ?\nLes tests PCR sont-ils utiles ?\nPeut-on confondre avec d'autres pneumonies ?",
"url": "https://questionsmedicales.fr/mesh/D061387#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Pneumonie à Chlamydia",
"description": "Quels sont les symptômes courants ?\nLa fatigue est-elle un symptôme ?\nY a-t-il des symptômes atypiques ?\nLes symptômes varient-ils selon l'âge ?\nLa toux est-elle productive ?",
"url": "https://questionsmedicales.fr/mesh/D061387#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Pneumonie à Chlamydia",
"description": "Comment prévenir la pneumonie à Chlamydia ?\nLes vaccins sont-ils disponibles ?\nLe tabagisme augmente-t-il le risque ?\nLes masques aident-ils à prévenir ?\nL'hygiène des mains est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D061387#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Pneumonie à Chlamydia",
"description": "Quel est le traitement principal ?\nLes antiviraux sont-ils efficaces ?\nCombien de temps dure le traitement ?\nDes soins de soutien sont-ils nécessaires ?\nLes antibiotiques sont-ils toujours efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D061387#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Pneumonie à Chlamydia",
"description": "Quelles sont les complications possibles ?\nLa pneumonie peut-elle être mortelle ?\nLes complications sont-elles fréquentes ?\nComment surveiller les complications ?\nLes complications affectent-elles la récupération ?",
"url": "https://questionsmedicales.fr/mesh/D061387#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Pneumonie à Chlamydia",
"description": "Quels sont les facteurs de risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes maladies chroniques augmentent-elles le risque ?\nLe stress affecte-t-il le risque ?\nLes voyages augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D061387#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la pneumonie à Chlamydia ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et des cultures de prélèvements respiratoires."
}
},
{
"@type": "Question",
"name": "Quels examens sont recommandés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des radiographies thoraciques et des analyses de sang peuvent être effectuées."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes comme la toux et la fièvre orientent vers une pneumonie."
}
},
{
"@type": "Question",
"name": "Les tests PCR sont-ils utiles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR peut détecter l'ADN de Chlamydia pneumoniae dans les échantillons."
}
},
{
"@type": "Question",
"name": "Peut-on confondre avec d'autres pneumonies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la pneumonie à Chlamydia peut être confondue avec d'autres infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, fièvre, essoufflement et douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue est fréquente chez les patients atteints de pneumonie à Chlamydia."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes atypiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des maux de tête ou des douleurs musculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants et les personnes âgées peuvent présenter des symptômes différents."
}
},
{
"@type": "Question",
"name": "La toux est-elle productive ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La toux peut être sèche ou productive, selon la gravité de l'infection."
}
},
{
"@type": "Question",
"name": "Comment prévenir la pneumonie à Chlamydia ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne hygiène et l'évitement des contacts avec des personnes malades."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils disponibles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin spécifique contre Chlamydia pneumoniae."
}
},
{
"@type": "Question",
"name": "Le tabagisme augmente-t-il le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter le risque de pneumonie et d'autres infections respiratoires."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter un masque peut réduire la transmission des infections respiratoires."
}
},
{
"@type": "Question",
"name": "L'hygiène des mains est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, se laver les mains régulièrement aide à prévenir la propagation des infections."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques comme l'azithromycine ou la doxycycline sont utilisés."
}
},
{
"@type": "Question",
"name": "Les antiviraux sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antiviraux ne sont pas efficaces contre les infections bactériennes comme celle-ci."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dure généralement 7 à 14 jours, selon la gravité de l'infection."
}
},
{
"@type": "Question",
"name": "Des soins de soutien sont-ils nécessaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins de soutien comme l'hydratation et le repos sont recommandés."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils toujours efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La résistance aux antibiotiques peut réduire leur efficacité dans certains cas."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance respiratoire et les infections secondaires."
}
},
{
"@type": "Question",
"name": "La pneumonie peut-elle être mortelle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans les cas graves, la pneumonie à Chlamydia peut entraîner la mort."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir, surtout chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier est essentiel pour détecter les complications précoces."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la récupération ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent prolonger le temps de récupération et nécessiter des soins intensifs."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'immunodépression et l'âge avancé."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru de développer des pneumonies."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou les maladies pulmonaires chroniques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages dans des zones à forte incidence de pneumonie peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 23/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Departments of Microbiology, Immunology, and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA Xuemin5908@sina.com Zhongg@uthscsa.edu.
Publications dans "Pneumonie à Chlamydia" :
4 publications dans cette catégorie
Affiliations :
School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Qld, Australia.
Publications dans "Pneumonie à Chlamydia" :
4 publications dans cette catégorie
Affiliations :
Animal Research Centre, University of the Sunshine Coast, Sippy Downs, QLD, Australia.
Publications dans "Pneumonie à Chlamydia" :
4 publications dans cette catégorie
Affiliations :
Institute of Veterinary Pathology, Department of Pathobiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Geelong, VIC 3216, Australia.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Geelong, VIC 3216, Australia.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Geelong, VIC 3216, Australia.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Qld, Australia.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Qld, Australia.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Faculty of Science, Health, Education and Engineering, University of the Sunshine Coast, Sippy Downs, Queensland, Australia.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Francis I. Proctor Foundation, University of California, San Francisco, California.
Department of Ophthalmology, University of California, San Francisco, California.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Francis I. Proctor Foundation, University of California, San Francisco, California.
Department of Ophthalmology, University of California, San Francisco, California.
Department of Epidemiology & Biostatistics, University of California, San Francisco, California.
Institute for Global Health, University of California, San Francisco, California.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Francis I. Proctor Foundation, University of California, San Francisco, California.
Department of Ophthalmology, University of California, San Francisco, California.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Department of Immunology, Rady Max College of Medicine, University of Manitoba, Winnipeg, MB R3E 0T5, Canada.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Department of Immunology, Rady Max College of Medicine, University of Manitoba, Winnipeg, MB R3E 0T5, Canada.
Publications dans "Pneumonie à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Department of Immunology, Rady Max College of Medicine, University of Manitoba, Winnipeg, MB R3E 0T5, Canada.
Publications dans "Pneumonie à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Publications dans "Pneumonie à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Centre for Microbiology and Environmental Systems Science, University of Vienna, Vienna, Austria.
Doctoral School in Microbiology and Environmental Science, University of Vienna, Vienna, Austria.
Publications dans "Pneumonie à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Centre for Microbiology and Environmental Systems Science, University of Vienna, Vienna, Austria.
Publications dans "Pneumonie à Chlamydia" :
Psittacosis pneumonia is a community-acquired pneumonia caused by Chlamydia psittaci. It is usually under-diagnosed due to its atypical clinical presentation and lack of routine laboratory tests....
To better understand the clinical features, 52 patients diagnosed with psittacosis pneumonia by metagenomic next-generation sequencing (mNGS) were enrolled in this study. The clinical, radiological an...
The onset of psittacosis pneumonia in this study occurred all year round, with a peak from December to January. Most of the patients were 51-80 years old. About 65.38% of patients had a history of exp...
In conclusion, mNGS may be a promising approach for clinical diagnosis of psittacosis. For patients with a history of exposure to birds, hyperpyrexia, nonproductive cough, multiple elevated inflammato...
Chlamydia abortus, as a pathogen of atypical pneumonia, is rare in humans, especially in HIV infection patients....
We present the case of a 48-year-old man with a history of HIV infection who started high fever and developed pneumonia. The pathogen-targeted next-generation sequencing (ptNGS) results of bronchial l...
This is the first report of Chlamydia abortus infection presented as atypical pneumonia in an AIDS patient....
4-Chloroisocoumarin compounds have broad inhibitory properties against serine proteases. Here, we show that selected 3-alkoxy-4-chloroisocoumarins preferentially inhibit the activity of the conserved ...
Viral conjunctivitis is the most common type of conjunctivitis. It is contagious and is predominantly seen as adenovirus-related conjunctivitis and keratoconjunctivitis (ADV). These infections are the...
Recently, the incidence of chlamydial pneumonia caused by rare pathogens such as...
In the present study, we investigated both the pathogenic profile characteristics and the lower respiratory tract microbiota of pneumonia patients with different chlamydial infection patterns using mN...
More co-infecting pathogens were found to be detectable in clinical samples from patients infected with...
The present study provides possible evidences supporting the close correlation between chlamydial infection, altered microbial diversity in patients' lungs and clinical parameters associated with infe...
The obligate intracellular bacterium...
The phylum Chlamydiae consists of obligate intracellular bacteria including major human pathogens and diverse environmental representatives. Here we investigated the Rhabdochlamydiaceae, which is pred...
A retrospective study was conducted at our institution of all patients who delivered between May 2016 and April 2017. A change of practice had been instituted, which involved obstetricians testing for...
Sexually transmitted infections (STIs) constitute one of the leading causes of disease burden worldwide, leading to considerable morbidity, mortality, health expenditures, and stigma. Of note are the ...
To assess the relationship between self-reported and serologic evidence of prior chlamydial infection, rheumatoid arthritis (RA)-related autoantibodies and risk of RA-development....
This is a nested study within a prospective Swiss-based cohort including all first-degree relatives of RA patients (RA-FDR) who answered a question on past chlamydial infections. Primary outcome was s...
Among 1231 RA-FDRs, 168 (13.6%) developed RA-autoimmunity. Prevalence of self-reported chlamydial infection was significantly higher in individuals with RA-autoimmunity compared with controls (17.9% v...
Self-reported chlamydial infections are associated with elevated RA-autoimmunity in at risk individuals. The differing association of chlamydial infections and ACPA/RF between cohorts will need to be ...